Over the past 24 years working in top 10 pharmaceutical companies, he established the Market Access, Health Economics and Outcomes Research functions, and led the development and implementation of market access strategies for many high-value innovative products in both developed and emerging markets. He has also published 36 peer-reviewed papers, delivered well over 70 oral presentations and abstracts, has given numerous keynote lectures and presentations at international scientific meetings on cost effectiveness in healthcare, health technology assessment, and market access, and has participated in many forums around key policy issues shaping the healthcare environment.

His expertise in healthcare is on access to medicine, evidence-based medicine and policy decisions, value-based care, pharmaceutical pricing, reimbursement, and real world evidence generation. He continues to have an adjunct appointment at the University of Illinois at Chicago, College of Pharmacy.